Journal List > J Rheum Dis > v.20(2) > 1064030

Yang, Hong, Lim, Jang, Jeon, and Yoo: A Case of ANA-negative, Anti-dsDNA Negative, and Anti-Ro/SSA Positive Membranous Lupus Nephropathy

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of diverse autoantibodies with various systemic organ involvements. In patients with SLE, autoantibodies, such as antinuclear antibody (ANA) and anti-dsDNA antibody, play an important role not only in diagnosing the disease, but also representing the pathogenesis of the disease. ANA is the main screening tool in diagnosis and serum complement levels and anti-dsDNA antibody level are closely related to the disease activities. Nevertheless, exceptionally, some patients represent with negative ANA and/or anti-dsDNA antibody leading to diffi-culties in diagnosing the disease. Here, we report a case of 37-year old female SLE patient with negative ANA, negative anti-dsDNA antibody, and positive anti-Ro/SSA antibody, which manifested with nephrotic syndrome.

References

1. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology. 5th ed.p. 2228. Philadel-phia: Elsevier Mosby;2010.
2. McHardy KC, Horne CH, Rennie J. Antinuclear antibody-negative systemic lupus erythematosus-how common? J Clin Pathol. 1982; 35:1118–21.
crossref
3. Fessel WJ. ANA-negative systemic lupus erythematosus. Am J Med. 1978; 64:80–6.
crossref
4. Maddison PJ, Provost TT, Reichlin M. Serological findings in patients with "ANA-negative" systemic lupus erythematosus. Medicine (Baltimore). 1981; 60:87–94.
crossref
5. Min DJ, Kim HK. Prevalence and the antigenic determi-nant of Anti-Ro/SS-A antibody in patients with systemic lupus erythematosus. The Journal of Catholic Medical College. 1995; 48:705–13.
6. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum. 1991; 21:55–64.
crossref
7. Ozdemir FN, Elsurer R, Akcay A, Ozdemir BH, Sezer S, Kuscu E, et al. Seronegative systemic lupus erythematosus: etiology of nephrotic syndrome and acute renal failure in early postpartum period. Lupus. 2005; 14:629–31.
8. Caltik A, Demircin G, Bü lbül M, Erdogan O, Akyüz SG, Arda N. An unusual case of ANA negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and full-house nephropathy. Rheumatol Int. 2013; 33:219–22.
crossref
9. Xie Q, Liu Y, Yang N, Yin G. Antinuclear antibody-ne-gative systemic lupus erythematosus in a case with pre-gnancy. Rheumatol Int. 2012; 32:3273–6.
crossref
10. Kim HY, Park JS, Oh HJ, Shin DK, Oh JS, Park KM, et al. ANA negative lupus nephritis with ulnar nerve neuropathy. Korean J Nephrol. 2010; 29:352.
11. Kim HA, Chung JW, Park HJ, Joe DY, Yim HE, Park HS, et al. An antinuclear antibody-negative patient with lupus nephritis. Korean J Intern Med. 2009; 24:76–9.
crossref
12. Maraina CH, Kamaliah MD, Ishak M. ANA negative (Ro) lupus erythematosus with multiple major organ involvement: a case report. Asian Pac J Allergy Immunol. 2002; 20:279–82.
13. Baskin E, Agras PI, Menekşe N, Ozdemir H, Cengiz N. Full-house nephropathy in a patient with negative serol-ogy for lupus. Rheumatol Int. 2007; 27:281–4.
crossref
14. Carter JD, Valeriano-Marcet J, Kanik KS, Vasey FB. Antinuclear antibody-negative, drug-induced lupus caused by lisinopril. South Med J. 2001; 94:1122–3.
15. Cobeñas CJ, Spizziri FD, Drut R. Membranous nephropathy and seronegative systemic lupus erythematosus. Pediatr Nephrol. 2003; 18:202–3.
crossref

Figure 1.
Pathologic findings of renal biopsy showed lupus nephritis, class V.
jrd-20-127f1.tif
Figure 2.
Immunofluorescence findings of renal biopsy.
jrd-20-127f2.tif
Table 1.
Comparative analysis of ANA negative lupus nephrits (8–15)
Case 1 (8) 2 (9) 3 (10) 4 (11) 5 (12) 6 (13) 7 (14) 8 (15) Our case
Age 13 30 51 16 22 10 44 5 month 37
Sex M F M F F F F F F
Rash (malar/discoid) (+) (+) : malar (-) (+) : malar (+) : malar (-) (-) (-) (+) : malar
Photosensitivity (-) (-) (-) (+) (+) (-) (-) (-) (-)
Oral ulcer (-) (-) (-) (-) (+) (-) (-) (-) (-)
Arthritis (+) (+) (-) (+) (+) (-) (-) (-) (-)
Renal d/o (+) IV (+) (+) IV (+) III (+) I (+) III (-) (+) V (+) V
Pleuritis/pericarditis (+) (+) (-) (+) (-) (-) (+) (-) (-)
Neurologic d/o (-) Seizure (-) (-) Seizure (-) (-) (-) (-)
Hematologic d/o Hemolytic anemia Lymphopenia, hemolytic anemia Lymphopenia Lymphopenia Thrombocytopenia (-) (-) Hemolytic anemia, thrombocytopenia Hemolytic anemia thrombocytopenia
Immunologic d/o dsDNA/Sm/aPL All (-) All (-) All (-) All (-) Not done (-/-/+) All (-) All (-) All (-)
ANA (-) (-) (-) (-) (-) (-) (-) (-) (-)
Number of succeptible criteria 5 6 2 6 7 2 1 2 3
 Autoantibodies                  
Ro U/K (+) (+) (-) (+) (-) (-) (-) (+)
La U/K (-) U/K (-) (-) (-) (-) (-) (-)
RNP U/K (-) U/K (-) U/K (-) (-) (-) (-)
ANCA (-) (-) U/K U/K U/K (-) (-) U/K (-)
Treatment Steroid pulse immunosuppressive agent Steroid pulse immunosuppressive agent, abortion Steroid PO MMF Steroid pulse immunosuppressive agent Steroid pulse Steroid pulse immunosuppressive agent Steroid Steroid pulse, IVIG, immunosuppressive agent Steroid pulse immunosuppressive agent
Others Vasculitis, peritonitis Pregnant HBV(+), CTS   Vasculitis Abdominal pain Anti-histone(+), lisinopril    

ANA: antinuclear antibody, ANCA: Anti-neutrophil cytoplasmic antibody, CTS: carpal tunnel syndrome, d/o: disorder, F: female, HBV: hepatitis B virus, IV: intravenous, IVIG: intravenous immunoglobulin, La: SS-B, M: male, MMF: mycofenolate mofetil, PO: per oral, RNP: ribonucleoprotein, Ro: SS-A, U/K: unknown

TOOLS
Similar articles